GSK survey finds COVID, lack of early HCP conversations hitting lupus patients' care

A new survey out by lupus drug maker GSK has found that nearly half of surveyed healthcare professionals believe patients with lupus have not been getting “optimal care” over the past two years, with COVID-19 and doctors not talking about organ damage at diagnosis with their patients the key factors.